Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases Canada NewsWire VICTORIA, BC, Sept. 19, 2024 VICTORIA, BC, Sept. 19, 2024 /CNW/ - Eupraxia Pharmaceuticals...
Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Sept. 11, 2024 Consistent improvement in...
Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference Canada NewsWire VICTORIA, BC, Sept. 4, 2024 VICTORIA, BC, Sept. 4, 2024 /CNW/ - Eupraxia...
Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results Canada NewsWire VICTORIA, BC, Aug. 7, 2024 VICTORIA, BC, Aug. 7, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc...
Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility Canada NewsWire VICTORIA, BC, Aug. 2, 2024 The Company also provides an update on the Silicon Valley Bank convertible...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.44 | 12.9032258065 | 3.41 | 3.9 | 3.38 | 24056 | 3.58066262 | CS |
4 | 0.34 | 9.68660968661 | 3.51 | 3.9 | 3.24 | 23196 | 3.49633174 | CS |
12 | 0.34 | 9.68660968661 | 3.51 | 4.4 | 3.24 | 17588 | 3.54023319 | CS |
26 | -0.46 | -10.6728538283 | 4.31 | 4.79 | 3.24 | 27326 | 3.81506034 | CS |
52 | -3.79 | -49.6073298429 | 7.64 | 7.64 | 3.24 | 31348 | 4.71567422 | CS |
156 | 1.24 | 47.5095785441 | 2.61 | 9.1 | 0.8 | 26635 | 4.16650784 | CS |
260 | -3.9 | -50.3225806452 | 7.75 | 9.1 | 0.8 | 24705 | 4.23280714 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.